According to Latest Research by Market IntelliX, the global market for Syndromic Testing should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Syndromic Testing market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Syndromic Testing market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Respiratory Infections segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Outbreak Response has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.
The global key manufacturers of Syndromic Testing include Thermo Fisher Scientific Inc., Qiagen, Abbott Diagnostics, Vela Diagnostics, Veramarx, Visby Medical, XCR Diagnostics, Beckman Coulter Diagnostics and Becton, Dickinson and Company, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
Syndromic testing is the process of using one test to simultaneously target multiple pathogens with overlapping signs and symptoms.Syndromic testing is a type of testing used in medical diagnosis that looks for multiple different infectious agents at the same time, often based on the symptoms and signs exhibited by the patient. This type of testing is usually performed when a patient presents with symptoms that are difficult to diagnose or when there is a suspected outbreak of an infectious disease.Syndromic testing is a useful tool in the diagnosis and management of infectious diseases.
This report aims to provide a comprehensive study of the global market for Syndromic Testing. Report Highlights:
(1) Global Syndromic Testing market size (value), history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Syndromic Testing market competitive situation, revenue and market share, from 2019 to 2024.
(3) China Syndromic Testing market competitive situation, revenue and market share, from 2019 to 2024.
(4) Global Syndromic Testing segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Syndromic Testing segment by type and by application and regional segment by type and by application.
(6) Syndromic Testing industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Respiratory Infections
Sexually Transmitted Infections (STIs)
Gastrointestinal Infections
Central Nervous System Infections
Others
Market segment by application, can be divided into
Outbreak Response
Emergency Departments
Travel Medicine
Military Medicine
Public Health Surveillance
Market segment by players, this report covers
Thermo Fisher Scientific Inc.
Qiagen
Abbott Diagnostics
Vela Diagnostics
Veramarx
Visby Medical
XCR Diagnostics
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc
Bosch Healthcare Solutions GmbH
Genetic Signatures
GenMark Dx (Roche)
Hologic
Roche Molecular Diagnostics
1 Market Overview
1.1 Product Overview and Scope of Syndromic Testing
1.2 Global Syndromic Testing Market Size and Forecast
1.3 China Syndromic Testing Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Syndromic Testing Share in Global Market, 2019-2030
1.4.2 Syndromic Testing Market Size: China VS Global, 2019-2030
1.5 Syndromic Testing Market Dynamics
1.5.1 Syndromic Testing Market Drivers
1.5.2 Syndromic Testing Market Restraints
1.5.3 Syndromic Testing Industry Trends
1.5.4 Syndromic Testing Industry Policy
2 Global Competitive Situation by Company
2.1 Global Syndromic Testing Revenue by Company (2019-2024)
2.2 Global Syndromic Testing Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Syndromic Testing Concentration Ratio
2.4 Global Syndromic Testing Mergers & Acquisitions, Expansion Plans
2.5 Global Syndromic Testing Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Syndromic Testing Revenue by Company (2019-2024)
3.2 China Syndromic Testing Syndromic Testing Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Syndromic Testing, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)
4 Industry Chain Analysis
4.1 Syndromic Testing Industry Chain
4.2 Syndromic Testing Upstream Analysis
4.3 Syndromic Testing Midstream Analysis
4.4 Syndromic Testing Downstream Analysis
5 Sights by Type
5.1 Syndromic Testing Classification
5.1.1 Respiratory Infections
5.1.2 Sexually Transmitted Infections (STIs)
5.1.3 Gastrointestinal Infections
5.1.4 Central Nervous System Infections
5.1.5 Others
5.2 By Type, Global Syndromic Testing Market Size & CAGR, 2019 VS 2024 VS 2030
5.3 By Type, Global Syndromic Testing Revenue, 2019-2030
6 Sights by Application
6.1 Syndromic Testing Segment by Application
6.1.1 Outbreak Response
6.1.2 Emergency Departments
6.1.3 Travel Medicine
6.1.4 Military Medicine
6.1.5 Public Health Surveillance
6.2 By Application, Global Syndromic Testing Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Application, Global Syndromic Testing Revenue, 2019-2030
7 Sales Sights by Region
7.1 By Region, Global Syndromic Testing Market Size, 2019 VS 2024 VS 2030
7.2 By Region, Global Syndromic Testing Market Size, 2019-2030
7.3 North America
7.3.1 North America Syndromic Testing Market Size & Forecasts, 2019-2030
7.3.2 By Country, North America Syndromic Testing Market Size Market Share
7.4 Europe
7.4.1 Europe Syndromic Testing Market Size & Forecasts, 2019-2030
7.4.2 By Country, Europe Syndromic Testing Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Syndromic Testing Market Size & Forecasts, 2019-2030
7.5.2 By Country/Region, Asia Pacific Syndromic Testing Market Size Market Share
7.6 South America
7.6.1 South America Syndromic Testing Market Size & Forecasts, 2019-2030
7.6.2 By Country, South America Syndromic Testing Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Syndromic Testing Market Size & CAGR,2019 VS 2024 VS 2030
8.2 By Country, Global Syndromic Testing Market Size, 2019-2030
8.3 U.S.
8.3.1 U.S. Syndromic Testing Market Size, 2019-2030
8.3.2 By Company, U.S. Syndromic Testing Revenue Market Share, 2019-2024
8.3.3 By Type, U.S. Syndromic Testing Revenue Market Share, 2024 VS 2030
8.3.4 By Application, U.S. Syndromic Testing Revenue Market Share, 2024 VS 2030
8.4 Europe
8.4.1 Europe Syndromic Testing Market Size, 2019-2030
8.4.2 By Company, Europe Syndromic Testing Revenue Market Share, 2019-2024
8.4.3 By Type, Europe Syndromic Testing Revenue Market Share, 2024 VS 2030
8.4.4 By Application, Europe Syndromic Testing Revenue Market Share, 2024 VS 2030
8.5 China
8.5.1 China Syndromic Testing Market Size, 2019-2030
8.5.2 By Company, China Syndromic Testing Revenue Market Share, 2019-2024
8.5.3 By Type, China Syndromic Testing Revenue Market Share, 2024 VS 2030
8.5.4 By Application, China Syndromic Testing Revenue Market Share, 2024 VS 2030
8.6 Japan
8.6.1 Japan Syndromic Testing Market Size, 2019-2030
8.6.2 By Company, Japan Syndromic Testing Revenue Market Share, 2019-2024
8.6.3 By Type, Japan Syndromic Testing Revenue Market Share, 2024 VS 2030
8.6.4 By Application, Japan Syndromic Testing Revenue Market Share, 2024 VS 2030
8.7 South Korea
8.7.1 South Korea Syndromic Testing Market Size, 2019-2030
8.7.2 By Company, South Korea Syndromic Testing Revenue Market Share, 2019-2024
8.7.3 By Type, South Korea Syndromic Testing Revenue Market Share, 2024 VS 2030
8.7.4 By Application, South Korea Syndromic Testing Revenue Market Share, 2024 VS 2030
8.8 Southeast Asia
8.8.1 Southeast Asia Syndromic Testing Market Size, 2019-2030
8.8.2 By Company, Southeast Asia Syndromic Testing Revenue Market Share, 2019-2024
8.8.3 By Type, Southeast Asia Syndromic Testing Revenue Market Share, 2024 VS 2030
8.8.4 By Application, Southeast Asia Syndromic Testing Revenue Market Share, 2024 VS 2030
8.9 India
8.9.1 India Syndromic Testing Market Size, 2019-2030
8.9.2 By Company, India Syndromic Testing Revenue Market Share, 2019-2024
8.9.3 By Type, India Syndromic Testing Revenue Market Share, 2024 VS 2030
8.9.4 By Application, India Syndromic Testing Revenue Market Share, 2024 VS 2030
8.10 Middle East & Asia
8.10.1 Middle East & Asia Syndromic Testing Market Size, 2019-2030
8.10.2 By Company, Middle East & Asia Syndromic Testing Revenue Market Share, 2019-2024
8.10.3 By Type, Middle East & Asia Syndromic Testing Revenue Market Share, 2024 VS 2030
8.10.4 By Application, Middle East & Asia Syndromic Testing Revenue Market Share, 2024 VS 2030
9 Global Manufacturers Profile
9.1 Thermo Fisher Scientific Inc.
9.1.1 Thermo Fisher Scientific Inc. Company Information, Head Office, Market Area and Industry Position
9.1.2 Thermo Fisher Scientific Inc. Company Profile and Main Business
9.1.3 Thermo Fisher Scientific Inc. Syndromic Testing Models, Specifications and Application
9.1.4 Thermo Fisher Scientific Inc. Syndromic Testing Revenue and Gross Margin, 2019-2024
9.1.5 Thermo Fisher Scientific Inc. Recent Developments
9.2 Qiagen
9.2.1 Qiagen Company Information, Head Office, Market Area and Industry Position
9.2.2 Qiagen Company Profile and Main Business
9.2.3 Qiagen Syndromic Testing Models, Specifications and Application
9.2.4 Qiagen Syndromic Testing Revenue and Gross Margin, 2019-2024
9.2.5 Qiagen Recent Developments
9.3 Abbott Diagnostics
9.3.1 Abbott Diagnostics Company Information, Head Office, Market Area and Industry Position
9.3.2 Abbott Diagnostics Company Profile and Main Business
9.3.3 Abbott Diagnostics Syndromic Testing Models, Specifications and Application
9.3.4 Abbott Diagnostics Syndromic Testing Revenue and Gross Margin, 2019-2024
9.3.5 Abbott Diagnostics Recent Developments
9.4 Vela Diagnostics
9.4.1 Vela Diagnostics Company Information, Head Office, Market Area and Industry Position
9.4.2 Vela Diagnostics Company Profile and Main Business
9.4.3 Vela Diagnostics Syndromic Testing Models, Specifications and Application
9.4.4 Vela Diagnostics Syndromic Testing Revenue and Gross Margin, 2019-2024
9.4.5 Vela Diagnostics Recent Developments
9.5 Veramarx
9.5.1 Veramarx Company Information, Head Office, Market Area and Industry Position
9.5.2 Veramarx Company Profile and Main Business
9.5.3 Veramarx Syndromic Testing Models, Specifications and Application
9.5.4 Veramarx Syndromic Testing Revenue and Gross Margin, 2019-2024
9.5.5 Veramarx Recent Developments
9.6 Visby Medical
9.6.1 Visby Medical Company Information, Head Office, Market Area and Industry Position
9.6.2 Visby Medical Company Profile and Main Business
9.6.3 Visby Medical Syndromic Testing Models, Specifications and Application
9.6.4 Visby Medical Syndromic Testing Revenue and Gross Margin, 2019-2024
9.6.5 Visby Medical Recent Developments
9.7 XCR Diagnostics
9.7.1 XCR Diagnostics Company Information, Head Office, Market Area and Industry Position
9.7.2 XCR Diagnostics Company Profile and Main Business
9.7.3 XCR Diagnostics Syndromic Testing Models, Specifications and Application
9.7.4 XCR Diagnostics Syndromic Testing Revenue and Gross Margin, 2019-2024
9.7.5 XCR Diagnostics Recent Developments
9.8 Beckman Coulter Diagnostics
9.8.1 Beckman Coulter Diagnostics Company Information, Head Office, Market Area and Industry Position
9.8.2 Beckman Coulter Diagnostics Company Profile and Main Business
9.8.3 Beckman Coulter Diagnostics Syndromic Testing Models, Specifications and Application
9.8.4 Beckman Coulter Diagnostics Syndromic Testing Revenue and Gross Margin, 2019-2024
9.8.5 Beckman Coulter Diagnostics Recent Developments
9.9 Becton, Dickinson and Company
9.9.1 Becton, Dickinson and Company Company Information, Head Office, Market Area and Industry Position
9.9.2 Becton, Dickinson and Company Company Profile and Main Business
9.9.3 Becton, Dickinson and Company Syndromic Testing Models, Specifications and Application
9.9.4 Becton, Dickinson and Company Syndromic Testing Revenue and Gross Margin, 2019-2024
9.9.5 Becton, Dickinson and Company Recent Developments
9.10 Bio-Rad Laboratories, Inc
9.10.1 Bio-Rad Laboratories, Inc Company Information, Head Office, Market Area and Industry Position
9.10.2 Bio-Rad Laboratories, Inc Company Profile and Main Business
9.10.3 Bio-Rad Laboratories, Inc Syndromic Testing Models, Specifications and Application
9.10.4 Bio-Rad Laboratories, Inc Syndromic Testing Revenue and Gross Margin, 2019-2024
9.10.5 Bio-Rad Laboratories, Inc Recent Developments
9.11 Bosch Healthcare Solutions GmbH
9.11.1 Bosch Healthcare Solutions GmbH Company Information, Head Office, Market Area and Industry Position
9.11.2 Bosch Healthcare Solutions GmbH Company Profile and Main Business
9.11.3 Bosch Healthcare Solutions GmbH Syndromic Testing Models, Specifications and Application
9.11.4 Bosch Healthcare Solutions GmbH Syndromic Testing Revenue and Gross Margin, 2019-2024
9.11.5 Bosch Healthcare Solutions GmbH Recent Developments
9.12 Genetic Signatures
9.12.1 Genetic Signatures Company Information, Head Office, Market Area and Industry Position
9.12.2 Genetic Signatures Company Profile and Main Business
9.12.3 Genetic Signatures Syndromic Testing Models, Specifications and Application
9.12.4 Genetic Signatures Syndromic Testing Revenue and Gross Margin, 2019-2024
9.12.5 Genetic Signatures Recent Developments
9.13 GenMark Dx (Roche)
9.13.1 GenMark Dx (Roche) Company Information, Head Office, Market Area and Industry Position
9.13.2 GenMark Dx (Roche) Company Profile and Main Business
9.13.3 GenMark Dx (Roche) Syndromic Testing Models, Specifications and Application
9.13.4 GenMark Dx (Roche) Syndromic Testing Revenue and Gross Margin, 2019-2024
9.13.5 GenMark Dx (Roche) Recent Developments
9.14 Hologic
9.14.1 Hologic Company Information, Head Office, Market Area and Industry Position
9.14.2 Hologic Company Profile and Main Business
9.14.3 Hologic Syndromic Testing Models, Specifications and Application
9.14.4 Hologic Syndromic Testing Revenue and Gross Margin, 2019-2024
9.14.5 Hologic Recent Developments
9.15 Roche Molecular Diagnostics
9.15.1 Roche Molecular Diagnostics Company Information, Head Office, Market Area and Industry Position
9.15.2 Roche Molecular Diagnostics Company Profile and Main Business
9.15.3 Roche Molecular Diagnostics Syndromic Testing Models, Specifications and Application
9.15.4 Roche Molecular Diagnostics Syndromic Testing Revenue and Gross Margin, 2019-2024
9.15.5 Roche Molecular Diagnostics Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Syndromic Testing Market Size & CAGR: China VS Global, (US$ Million), 2019-2030
Table 2. Syndromic Testing Market Restraints
Table 3. Syndromic Testing Market Trends
Table 4. Syndromic Testing Industry Policy
Table 5. Global Syndromic Testing Revenue by Company (2019-2024) & (US$ million)
Table 6. Global Syndromic Testing Revenue Market Share by Company (2019-2024)
Table 7. Global Syndromic Testing Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Syndromic Testing Mergers & Acquisitions, Expansion Plans
Table 9. Global Syndromic Testing Manufacturers Product Type
Table 10. China Syndromic Testing Revenue by Company (2019-2024) & (US$ million)
Table 11. China Syndromic Testing Revenue Market Share by Company (2019-2024)
Table 12. Global Key Players of Syndromic Testing Upstream (Raw Materials)
Table 13. Global Syndromic Testing Typical Customers
Table 14. Syndromic Testing Typical Distributors
Table 15. By Type, Global Syndromic Testing Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 16. By Application, Global Syndromic Testing Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 17. By Region, Global Syndromic Testing Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 18. By Region, Global Syndromic Testing Revenue, 2019-2030, US$ Million
Table 19. By Country, Global Syndromic Testing Revenue & CAGR,2019 VS 2024 VS 2030, US$ Million
Table 20. By Country, Global Syndromic Testing Revenue, 2019-2030, US$ Million
Table 21. By Country, Global Syndromic Testing Revenue Market Share, 2019-2030
Table 22. Thermo Fisher Scientific Inc. Company Information, Head Office, Market Area and Industry Position
Table 23. Thermo Fisher Scientific Inc. Company Profile and Main Business
Table 24. Thermo Fisher Scientific Inc. Syndromic Testing Models, Specifications and Application
Table 25. Thermo Fisher Scientific Inc. Syndromic Testing Revenue and Gross Margin, 2019-2024
Table 26. Thermo Fisher Scientific Inc. Recent Developments
Table 27. Qiagen Company Information, Head Office, Market Area and Industry Position
Table 28. Qiagen Company Profile and Main Business
Table 29. Qiagen Syndromic Testing Models, Specifications and Application
Table 30. Qiagen Syndromic Testing Revenue and Gross Margin, 2019-2024
Table 31. Qiagen Recent Developments
Table 32. Abbott Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 33. Abbott Diagnostics Company Profile and Main Business
Table 34. Abbott Diagnostics Syndromic Testing Models, Specifications and Application
Table 35. Abbott Diagnostics Syndromic Testing Revenue and Gross Margin, 2019-2024
Table 36. Abbott Diagnostics Recent Developments
Table 37. Vela Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 38. Vela Diagnostics Company Profile and Main Business
Table 39. Vela Diagnostics Syndromic Testing Models, Specifications and Application
Table 40. Vela Diagnostics Syndromic Testing Revenue and Gross Margin, 2019-2024
Table 41. Vela Diagnostics Recent Developments
Table 42. Veramarx Company Information, Head Office, Market Area and Industry Position
Table 43. Veramarx Company Profile and Main Business
Table 44. Veramarx Syndromic Testing Models, Specifications and Application
Table 45. Veramarx Syndromic Testing Revenue and Gross Margin, 2019-2024
Table 46. Veramarx Recent Developments
Table 47. Visby Medical Company Information, Head Office, Market Area and Industry Position
Table 48. Visby Medical Company Profile and Main Business
Table 49. Visby Medical Syndromic Testing Models, Specifications and Application
Table 50. Visby Medical Syndromic Testing Revenue and Gross Margin, 2019-2024
Table 51. Visby Medical Recent Developments
Table 52. XCR Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 53. XCR Diagnostics Company Profile and Main Business
Table 54. XCR Diagnostics Syndromic Testing Models, Specifications and Application
Table 55. XCR Diagnostics Syndromic Testing Revenue and Gross Margin, 2019-2024
Table 56. XCR Diagnostics Recent Developments
Table 57. Beckman Coulter Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 58. Beckman Coulter Diagnostics Company Profile and Main Business
Table 59. Beckman Coulter Diagnostics Syndromic Testing Models, Specifications and Application
Table 60. Beckman Coulter Diagnostics Syndromic Testing Revenue and Gross Margin, 2019-2024
Table 61. Beckman Coulter Diagnostics Recent Developments
Table 62. Becton, Dickinson and Company Company Information, Head Office, Market Area and Industry Position
Table 63. Becton, Dickinson and Company Company Profile and Main Business
Table 64. Becton, Dickinson and Company Syndromic Testing Models, Specifications and Application
Table 65. Becton, Dickinson and Company Syndromic Testing Revenue and Gross Margin, 2019-2024
Table 66. Becton, Dickinson and Company Recent Developments
Table 67. Bio-Rad Laboratories, Inc Company Information, Head Office, Market Area and Industry Position
Table 68. Bio-Rad Laboratories, Inc Company Profile and Main Business
Table 69. Bio-Rad Laboratories, Inc Syndromic Testing Models, Specifications and Application
Table 70. Bio-Rad Laboratories, Inc Syndromic Testing Revenue and Gross Margin, 2019-2024
Table 71. Bio-Rad Laboratories, Inc Recent Developments
Table 72. Bosch Healthcare Solutions GmbH Company Information, Head Office, Market Area and Industry Position
Table 73. Bosch Healthcare Solutions GmbH Company Profile and Main Business
Table 74. Bosch Healthcare Solutions GmbH Syndromic Testing Models, Specifications and Application
Table 75. Bosch Healthcare Solutions GmbH Syndromic Testing Revenue and Gross Margin, 2019-2024
Table 76. Bosch Healthcare Solutions GmbH Recent Developments
Table 77. Genetic Signatures Company Information, Head Office, Market Area and Industry Position
Table 78. Genetic Signatures Company Profile and Main Business
Table 79. Genetic Signatures Syndromic Testing Models, Specifications and Application
Table 80. Genetic Signatures Syndromic Testing Revenue and Gross Margin, 2019-2024
Table 81. Genetic Signatures Recent Developments
Table 82. GenMark Dx (Roche) Company Information, Head Office, Market Area and Industry Position
Table 83. GenMark Dx (Roche) Company Profile and Main Business
Table 84. GenMark Dx (Roche) Syndromic Testing Models, Specifications and Application
Table 85. GenMark Dx (Roche) Syndromic Testing Revenue and Gross Margin, 2019-2024
Table 86. GenMark Dx (Roche) Recent Developments
Table 87. Hologic Company Information, Head Office, Market Area and Industry Position
Table 88. Hologic Company Profile and Main Business
Table 89. Hologic Syndromic Testing Models, Specifications and Application
Table 90. Hologic Syndromic Testing Revenue and Gross Margin, 2019-2024
Table 91. Hologic Recent Developments
Table 92. Roche Molecular Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 93. Roche Molecular Diagnostics Company Profile and Main Business
Table 94. Roche Molecular Diagnostics Syndromic Testing Models, Specifications and Application
Table 95. Roche Molecular Diagnostics Syndromic Testing Revenue and Gross Margin, 2019-2024
Table 96. Roche Molecular Diagnostics Recent Developments
List of Figure
Figure 1. Syndromic Testing Picture
Figure 2. Global Syndromic Testing Industry Market Size and Forecast (US$ million) & (2019-2030)
Figure 3. China Syndromic Testing Revenue and Forecast (US$ million) & (2019-2030)
Figure 4. 2019-2030 China Syndromic Testing Market Share of Global
Figure 5. Global Syndromic Testing Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 6. Global Syndromic Testing Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024
Figure 7. China Syndromic Testing Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 8. China Syndromic Testing Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 9. Syndromic Testing Industry Chain
Figure 10. Respiratory Infections
Figure 11. Sexually Transmitted Infections (STIs)
Figure 12. Gastrointestinal Infections
Figure 13. Central Nervous System Infections
Figure 14. Others
Figure 15. By Type, Global Syndromic Testing Revenue, 2019-2030, US$ Million
Figure 16. By Type, Global Syndromic Testing Revenue Market Share, 2019-2030
Figure 17. Outbreak Response
Figure 18. Emergency Departments
Figure 19. Travel Medicine
Figure 20. Military Medicine
Figure 21. Public Health Surveillance
Figure 22. By Application, Global Syndromic Testing Revenue, 2019-2030, US$ Million
Figure 23. By Application, Global Syndromic Testing Revenue Market Share, 2019-2030
Figure 24. By Region, Global Syndromic Testing Revenue Market Share, 2019-2030
Figure 25. North America Syndromic Testing Revenue & Forecasts, 2019-2030, US$ Million
Figure 26. By Country, North America Syndromic Testing Revenue Market Share, 2019-2024
Figure 27. Europe Syndromic Testing Revenue & Forecasts, 2019-2030, US$ Million
Figure 28. By Country, Europe Syndromic Testing Revenue Market Share, 2019-2024
Figure 29. Asia Pacific Syndromic Testing Revenue & Forecasts, 2019-2030, US$ Million
Figure 30. By Country/Region, Asia Pacific Syndromic Testing Revenue Market Share, 2019-2024
Figure 31. South America Syndromic Testing Revenue & Forecasts, 2019-2030, US$ Million
Figure 32. By Country, South America Syndromic Testing Revenue Market Share, 2019-2024
Figure 33. Middle East & Africa Syndromic Testing Revenue & Forecasts, 2019-2030, US$ Million
Figure 34. U.S. Syndromic Testing Revenue, 2019-2030, (US$ Million)
Figure 35. By Company, U.S. Syndromic Testing Market Share, 2019-2024
Figure 36. By Type, U.S. Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 37. By Application, U.S. Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 38. Europe Syndromic Testing Revenue, 2019-2030, (US$ Million)
Figure 39. By Company, Europe Syndromic Testing Market Share, 2019-2024
Figure 40. By Type, Europe Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 41. By Application, Europe Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 42. China Syndromic Testing Revenue, 2019-2030, (US$ Million)
Figure 43. By Company, China Syndromic Testing Market Share, 2019-2024
Figure 44. By Type, China Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 45. By Application, China Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 46. Japan Syndromic Testing Revenue, 2019-2030, (US$ Million)
Figure 47. By Company, Japan Syndromic Testing Market Share, 2019-2024
Figure 48. By Type, Japan Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 49. By Application, Japan Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 50. South Korea Syndromic Testing Revenue, 2019-2030, (US$ Million)
Figure 51. By Company, South Korea Syndromic Testing Market Share, 2019-2024
Figure 52. By Type, South Korea Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 53. By Application, South Korea Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 54. Southeast Asia Syndromic Testing Revenue, 2019-2030, (US$ Million)
Figure 55. By Company, Southeast Asia Syndromic Testing Market Share, 2019-2024
Figure 56. By Type, Southeast Asia Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 57. By Application, Southeast Asia Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 58. India Syndromic Testing Revenue, 2019-2030, (US$ Million)
Figure 59. By Company, India Syndromic Testing Market Share, 2019-2024
Figure 60. By Type, India Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 61. By Application, India Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 62. Middle East & Asia Syndromic Testing Revenue, 2019-2030, (US$ Million)
Figure 63. By Company, Middle East & Asia Syndromic Testing Market Share, 2019-2024
Figure 64. By Type, Middle East & Asia Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 65. By Application, Middle East & Asia Syndromic Testing Revenue Market Share, 2023 VS 2030
Figure 66. Research Methodology
Figure 67. Breakdown of Primary Interviews
Figure 68. Bottom-up Approaches
Figure 69. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|